Brainstorm Cell Therapeutics Inc. (BCLI)

Short-Term Debt

$1.37M

Quarterly · Period ending: · USD

BCLI logo

BCLI Short-Term Debt

Latest reported$1.37M
BCLI Quarterly Short-Term Debt ($0.00 → $1.37M)
High-resolution chart · PNG

BCLI short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Brainstorm Cell Therapeutics Inc. Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
1,374,000
1,488,000
1,383,000
377,000
482,000
1,643,000
549,000
570,000
566,000
588,000
603,000
1,306,000
1,354,000
1,389,000
1,427,000
1,460,000
1,478,000
1,629,000
1,461,000
1,735,000
2,037,000
2,299,000
2,655,000
1,216,000
1,224,000
1,208,000
1,263,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
137,000
41,000
1,000
9,000
370,000
264,000
206,000
412,000
443,000
461,000
436,000
1,385,000
1,341,000
1,154,000
1,856,000
1,529,803
1,125,526
1,143,548
959,464
495,851
0
0
0
0
0
0
0
30,974
30,974
30,974
20,974
20,974
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.